Litcius/Paper detail

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer

Jessica E. Hawley, Aleksandar Obradović, Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Casey R. Ager, James McKiernan, Christopher B. Anderson, G. Joel DeCastro, Joshua Weintraub, Renu K. Virk, Israel Lowy, Jianhua Hu, Matthew G. Chaimowitz, Xinzheng V. Guo, Ya Zhang, Michael C. Haffner, Jeremy Worley, Mark N. Stein, Andrea Califano, Charles G. Drake

2023Cancer Cell75 citationsDOIOpen Access PDF

Topics & Concepts

Prostate cancerAndrogen deprivation therapyImmune systemImmunotherapyTumor microenvironmentMedicineCancer researchOncologyInternal medicineImmunologyCancerCancer Immunotherapy and BiomarkersProstate Cancer Treatment and ResearchImmunotherapy and Immune Responses
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer | Litcius